Cell type-specific inhibition of p53-mediated apoptosis by mdm2

EMBO Journal

Volumn 15, Issue 7, 1996, Pages 1596-1606

  Haupt, Ygal ^a   Barak, Yaacov ^a,b   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Apoptosis; mdm2; p53; Transactivation

Indexed keywords

CELL PROTEIN;

APOPTOSIS; ARTICLE; CELL GROWTH; DNA DAMAGE; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029985647     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00504.x     Document Type: Article

References (98)

1. Baker, S.J., Markowitz, S., Fearson, E.R., Willson, J.K.V. and Vogelstein. B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915.
2. Banks, L., Matlashewski, G. and Crawford, L. (1986) Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem., 159, 529-534.
3. Barak, Y. and Oren, M. (1992) Enhanced binding of a 95-kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11, 2115-2121.
4. Barak, Y., Juven, T., Haffner, R and Oren, M. (1993) mdm2 expression is induced by wild-type p53 activity. EMBO J., 12, 461-468.
5. Barak, Y. Gottlieb, E., Juven, G.T. and Oren, M. (1994) Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev., 8, 1739-1749.
6. Brown, D.R., Deb, S., Munoz, R.M., Subler, M.A. and Deb, S.R (1993) The tumor suppressor p53 and the oncoprotein simian virus-40 T-Antigen bind to overlapping domains on the Mdm2 protein. Mol. Cell. Biol., 13, 6849-6857.
7. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
8. Cahilly-Snyder, L., Yang-Feng, T., Francke, U. and George, D.L. (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Som. Cell Mol. Genet., 13, 235-244.
9. Canman, C.E., Gilmer, T.M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
10. Chen, C.Y., Oliner, J.D., Zhan, Q., Fornace, A.J., Vogelstein, B. and Kastan, M.B. (1994) Interactions between p53 and Mdm2 in a mammalian cell cycle checkpoint pathway. Proc. Natl Acad. Sci. USA, 91, 2684-2688
11. Chen, J.D., Marechal, V. and Levine, A.J. (1993) Mapping of the p53 and mdm-2 interaction domains Mol. Cell. Biol., 13, 4107-4114.
12. Chen, J.D., Lin, J.Y. and Levine, A.J. (1995) Regulation of transcription functions of the p53 tumour suppressor by the mdm-2 oncogene Mol. Med., 1, 141-152.
13. Cordon-Cardo, C. et al. (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res., 54, 794-799.
14. Corvi, R. et al. (1995) Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene, 10, 1081-1086.
15. Crook, T., Marston, N.J., Sara, E.A. and Vousden, K.H. (1994) Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79, 817-827.
16. 1 arrest. Cell, 76, 1013-1023.
17. El-Deiry, W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
18. El-Deiry, W.S. et al. (1994) WAF1/CIP/ is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169-1174.
19. Fakharzadeh, S., Trusko, R.S. and George, D.L. (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour line. EMBO J., 10, 1565-1569.
20. Fanning, E. and Knippers, R. (1992) Structure and function of simian virus-40 large tumorantigen. Annu. Rev. Biochem., 61, 55-85.
21. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R. and Prives, C. (1992) Wild-type p53 activates transcription in vitro. Nature, 358, 83-86.
22. Finlay, C.A. (1993) The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol., 13, 301-306
23. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. cell Biol. 119, 493-501.
24. Gottlieb, E., Haffner, R., von Ruden, T., Wagner, E.F. and Oren, M. (1994) Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J., 13, 1368-1374.
25. Haffner, R. and Oren, M. (1995) p53: biochemical properties and biological effects. Curr. Opin. Genet. Dev., 5, 84-90.
26. Haines, D.S., Landers, J.E., Engle, L.J. and George, D.L. (1994) Physical and functional interaction between wild-type p53 and Mdm2 proteins. Mol. Cell. Biol., 14, 1171-1178.
27. Harlow, E., Crawford, L V., Pim, D.C. and Williamson, N.M. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol., 34, 752-763.
28. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S J. (1993) The p21 CDK-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
29. Haupt, Y., Rowan, S. and Oren, M. (1995a) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10, 1563-1571.
30. Haupt, Y., Rowan, S., Shaulian, E., Vousden, H.K. and Oren, M. (1995b) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9, 2170-2183.
31. Hinds, P.W., Finlay, C A., Quartin, S.J., Baker, E.R., Fearon, B., Vogelstein, B. and Levine, A.J. (1990) Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells - a comparison of the hot spot mutant phenotype. Cell Growth Differ, 1, 571-580.
32. Hoppe-Seyler, F. and Butz, K. (1993) Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human colon papillomavirus type-16 E6, human Mdm-2 and mutant p53. J. Virol. 67, 3111-3117.
33. Howes, K.A., Ransom, N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M. and Windle, J.J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence or p53. Genes Dev., 8, 1300-1310.
34. Ishioka, C., Englert, C., Winge, P., Yan, Y.X., Engelstein, M. and Friend, S.H. (1995) Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 10, 1485-1492.
35. Johnson, P., Chung, S. and Benchimol, S. (1993) Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol., 13, 1456-1463.
36. Jones, S.N., Roe, A.E., Donehower, L.A. and Bradly, A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature, 378, 206-208.
37. Juven, T., Barak, Y., Zauberman, A., George, D.L. and Oren, M. (1993) Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene, 8, 3411-3416.
38. Kondo, S., Barnett, G.H., Hara, H., Morimura, T. and Takeuchi, J. (1995) Mdm2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene, 10, 2001-2006.
39. Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S.C., Huvos, A.G. and Healey, J.H. (1993) mdm2 gene amplification in metastatic osteosarcoma. Cancer Res., 53, 16-18.
40. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
41. Leach, F.S. et al. (1993) p53 mutation and mdm2 amplification in human soft tissue sarcomas. Cancer Res., 53, 2231-2234.
42. Levine, A.J. (1993) The tumor suppressor genes. Annu. Rev. Biochem., 62, 623-651.
43. Li, R., Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature, 371, 534-537.
44. Lin, J.Y, Chen, J.D., Elenbaas, B. and Levine, A.J. (1994) Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to Mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8, 1235-1246.
45. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
46. Lu, H. and Levine, A.J. (1995) Human TAF(II)31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl Acad. Sci. USA, 92, 5154-5158.
47. Ludlow, J.W. (1993) Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J., 7, 866-871.
48. McCann, A.H., Kirley, A., Caney, D.N., Corbally, N., Magee, H.M., Keating, G. and Dervan, P.A. (1995) Amplification of the mdm2 gene in human breast cancer and its association with Mdm2 and p53 protein status. Br. J. Cancer, 71, 981-985.
49. Mietz, J A., Unger, T., Huibregtse, J.M. and Howley, P.M. (1992) The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6-oncoprotein. EMBO J., 11, 5013-5020.
50. Mitsudomi, T. et al. (1992) p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7, 171-180.
51. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80, 293-299.
52. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.W., Lin, H.K., Liebermann, D.A., Hoffman, B. and Reed, J.C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
53. Momand, J., Zambetti, G P., Olson, D.C., George, D. and Levine, A J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
54. Montes de Oca Luna, R., Wagner, D.S. and Lozano, G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature, 378, 203-206.
55. Moran, E. (1993) Interaction of adenoviral proteins with pRB and p53 FASEB J., 7, 880-885.
56. Morgenbesser, S.D., Williams, B.O., Jacks, T. and DePinho, R.A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature, 371, 72-74.
57. Okamoto, K. and Beach, D. (1994) Cyclin G is a transcriptional target of the p53 tumor suppressor protein EMBO J., 13, 4816-4822.
58. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. and Vogelstein, B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas Nature, 358, 80-83.
59. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S , Gvuris, J., Kinzler, K.W. and Vogelstein, B. (1993) Oncoprotein Mdm2 conceals the activation domain of tumour suppressor-p53. Nature, 362, 857-860.
60. Oren, M. (1994) Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol., 5, 305.1-305.7.
61. Ory, K., Legros, Y., Auguin, C. and Soussi, T. (1994) Analysis of the most representative tumor-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of ceil proliferation. EMBO J., 13, 3496-3504.
62. Otto, A. and Deppert, W. (1993) Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53. Oncogene, 8, 2591-2603.
63. Owen-Schaub, L.B. et al. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol., 15, 3032-3040.
64. Pan, H. and Griep, A.E (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgeneic mice: implications for tumor suppressor gene function in development Genes Dev., 8, 1285-1299.
65. Perry, M.E., Piette, J., Zawadzki, J.A., Harvey, D. and Levine, A.J. (1993) The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl Acad. Sci. USA, 90, 11623-11627.
66. Picksley, S.M. and Lane, D.P. (1993) The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53? Bioessays, 15, 689-690.
67. Picksley, S.M., Vojtesek, B., Sparks, A. and Lane, D.P. (1994) Immunochemical analysis of the interaction of p53 with Mdm2; fine mapping of the Mdm2 binding site on p53 using synthetic peptides. Oncogene, 9, 2523-2529.
68. Pietenpol, J A., Tokino, T. Thiagalingam, S., Eldeiry, W.S., Kinzler, K.W. and Vogelstein, B. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Prac. Natl Acad. Sci. USA, 91, 1998-2002.
69. Price, B.D. and Park, S.J. (1994) DNA damage increases the levels of mdm2 messenger RNA in wt p53 human cells. Cancer Res., 54, 896-899.
70. Prives, C. and Manfredi, J.J. (1993) The p53 tumor suppressor protein: meeting review. Genes Dev., 7, 529-534.
71. Reed, M., Wang, Y., Mayr, G., Enderson, M.E., Schwedes, J.F and Tegtmeyer, P. (1993) p53 domains: suppression, transformation, and transactivation. Gene Exp., 3, 95-106.
72. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E.E. and Collins, V.P. (1993) Amplification and overexpression of the mdm2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53, 2736-2739.
73. Renzing, J. and Lane, D.P. (1995) p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. Oncogene, 10, 1865-1868.
74. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M and Vousden, K H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J , 15, 827-838.
75. Sabbatini, P, Chiou, S.K., Rao, L. and White, E. (1995a) Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol., 15, 1060-1070.
76. Sabbatini, P., Lin, J., Levine, J.A. and White, E. (1995b) Essential role for p53-mediated transcription in apoptosis but not growth suppression. Genes Der., 9, 2184-2192.
77. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. and Howley, P.M. (1990) The E6 oncoprotein encoded by human papillomavirus Type-16 and Type-18 promotes the degradation of p53. Cell, 63, 1129-1136.
78. Selvakumaran, M., Lin, H.K , Miyashita, T., Wang, H G., Krajewski, S., Reed, J.C., Hoffman, B. and Liebermann, D. (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
79. Shaulian, E., Zauberman, A., Milner, J., Davies, E.A. and Oren, M. (1993) Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation. EMBO J., 12, 2789-2797.
80. Shen, Y.Q. and Shenk, T. (1994) Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl Acad. Sci. USA, 91, 8940-8944.
81. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T. and Van Dyke, T. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell, 78, 703-711.
82. Thut, C.J., Chen, J.L., Klemm, R. and Tjian, R. (1995) p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science, 267, 100-104.
83. Unger, T., Nau, M.M., Segal, S. and Minna, J.D. (1992) p53-A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J., 11, 1383-1390.
84. Vogelstein, B. and Kinzler, K.W. (1992) p53 function and dysfunction. Cell, 70, 523-526.
85. Vojtesek, B., Bartek, J., Midgley, C.A. and Lane, D.P. (1992) An immunochemical analysis of the human nuclear phosphoprotein-p53-new monoclonal antibodies and epitope mapping using recombinant-p53. J. Immuno. Methods, 151, 237-244.
86. Vousden, K (1993) Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 7, 872-879.
87. Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature, 369, 574-578.
88. waf1/cip1. Genes Dev. 8, 2817-2830.
89. Wu, X.W., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53 mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
90. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D (1993) p21 is a universal inhibitor of cyclin kinases. Science, 366, 701-704.
91. Yew, P.R., Liu, X. and Berk, A.J. (1994) Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8, 190-202.
92. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Scichs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
93. Yonish-Rouach, E., Borde, J., Gotteland, M., Mishal, Z., Viron, A and May, E. (1994) Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Death Differ., 1, 39-47.
94. waf is contained in its N-terminal half ('half-WAF'). Oncogene, 11, 393-395.
95. Zauberman, A., Barak, Y., Ragimov, N., Levy, N. and Oren, M. (1993) Sequence-specific DNA binding by p53-identification of target sites and lack of binding to p53-Mdm2 complexes. EMBO J., 12, 2799-2808.
96. Zauberman, A., Lupo, A. and Oren, M. (1995a) Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10, 2361-2366.
97. Zauberman, A., Flusberg, D., Haupt, Y., Barak, Y. and Oren, M. (1995b) A functional p53-responsive intronic promoter is contained within the human mdm-2 gene. Nucleic Acids Res., 23, 2584-2592.
98. Zhu, Y.M., Bradbury, D.A. and Russell, N.H. (1994) Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br. J. Cancer. 69, 468-472.